Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTF1QVM)

DTT Name	Gastric H(+)/K(+) ATPase alpha (ATP4A) DTT Info
Gene Name	ATP4A

Molecule-Related Drug & Molecule List

Molecule-Related Drug List

Molecule Type:

DTT

DTP

DME

Drug Status:

Approved Drug(s)

Clinical Trial Drug(s)

Preclinical Drug(s)

Investigative Drug(s)

Download the Complete Related Drug List

2 Approved Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Dexlansoprazole	DM1DBV5	Erosive esophagitis	DA25.0	Approved	[1]
Rabeprazole	DMMZXIW	Bacterial infection	1A00-1C4Z	Approved	[2]
------------------------------------------------------------------------------------

2 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
AG-SPT201	DMJRQDG	Ulcerative colitis	DD71	Phase 3	[3]
API-023	DM6P93J	Gastroesophageal reflux disease	DA22.Z	Phase 1	[4]
------------------------------------------------------------------------------------

1 Preclinical Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Saliphenylhalamide	DMLMRGH	Solid tumour/cancer	2A00-2F9Z	Preclinical	[4]
------------------------------------------------------------------------------------

5 Investigative Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
ARH-1029	DM8NETP	Helicobacter infection	DA42-DA63	Investigative	[4]
CA-50040	DMCLN6M	Colorectal cancer	2B91.Z	Investigative	[4]
CDRI-85/92	DMQDA5W	Stomach ulcer	DA60.Z	Investigative	[4]
OPC-22575	DMO4WH9	Ulcerative colitis	DD71	Investigative	[4]
PA-10040	DMELTM2	Cardiovascular disease	BA00-BE2Z	Investigative	[4]
------------------------------------------------------------------------------------

Molecule Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

References

1	Clinical pipeline report, company report or official report of Takeda (2009).
2	Review article: rabeprazole's tolerability profile in clinical trials. Aliment Pharmacol Ther. 1999 Oct;13 Suppl 5:17-23.
3	Effects of pantoprazole, a novel H+/K+-ATPase inhibitor, on duodenal ulcerogenic and healing responses in rats: a comparative study with omeprazole and lansoprazole. J Gastroenterol Hepatol. 1999 Mar;14(3):251-7.
4	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 849).